Biopharma stocks take a beating as economic turmoil takes its toll — but some players with coronavirus efforts underway are up
The Biogen coronavirus outbreak has left most of its staff working from home — and it’s been no help for its share price. The stock …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
